article thumbnail

GSK gives Wave a lift with genetic medicine deal

Bio Pharma Dive

A four-year agreement between the companies comes with $170 million in cash and equity for Wave, which in recent years has dealt with clinical setbacks

Genetics 259
article thumbnail

CARsgen and Huadong Medicine to commercialise CT053 in mainland China

Pharmaceutical Technology

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lilly puts $700M into genetic medicine institute

Bio Pharma Dive

Building on Lilly's acquisition of Prevail Therapeutics, the Boston-based facility will use RNA- and DNA-based technologies to develop new drugs, while also supporting biotech startups in the area

Genetics 245
article thumbnail

Lilly and ProQR to expand genetic medicine development agreement

Pharmaceutical Technology

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.

Genetics 262
article thumbnail

Pfizer expands not-for-profit pledge to include more medicines

Bio Pharma Dive

The pharma is now committing to providing all of the roughly 500 products in its portfolio, including antibiotics and cancer drugs, to 45 lower-income countries

Medicine 153
article thumbnail

Building a bridge between science and medicine at Regeneron

Bio Pharma Dive

Michael Klingler shares how the Biostatistics & Data Management team solve unsolvable problems together

Medicine 208
article thumbnail

Blacksmith Medicines to merge with Forge Therapeutics

Pharmaceutical Technology

Blacksmith Medicines has signed a definitive merger agreement with Forge Therapeutics to create a combined entity that will discover and develop medicines targeting a large class of proteins called metalloenzymes.

Medicine 130
article thumbnail

Testing Facility Called “Game Changer” in Regenerative Medicine

Pharma Mirror

The post Testing Facility Called “Game Changer” in Regenerative Medicine appeared first on Pharma Mirror Magazine. Pharmaceutical Articles Industry article Pharmaceutical articles pharmaceutical testing Regenerative MedicineThe RegeneratOR Test Bed is an exciting game changer.

Medicine 130
article thumbnail

Building a bridge between science and medicine at Regeneron

Bio Pharma Dive

Wilson Caldwell talks about how he and the clinical operations team turn promise into reality for patients every day

Medicine 208
article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

The field of genomic medicine has reached a true turning point. In June 2022, the European Medicines Agency approved an adeno-associated viral (AAV) vector-based therapy for adults with Hemophilia A, making the treatment available to an estimated 3,200 eligible patients. [1]

Genome 206
article thumbnail

Prime Medicine raises $175M in one of the year’s largest biotech IPOs

Bio Pharma Dive

The gene editing startup is one of less than two dozen biotech companies to debut on Wall Street this year, as the pace of IPOs remains far off last year’s trajectory

article thumbnail

Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach

Bio Pharma Dive

The two drugmakers joined a long list of investors, including Pfizer and Sanofi, that have been funding the startup’s plan to develop a new type of lipid nanoparticle technology

Genetics 214
article thumbnail

Editas to seek partner for CRISPR medicine after lackluster study results

Bio Pharma Dive

While the biotech will not develop the gene editing therapy further on its own, CEO Gilmore O’Neill claimed the data are still a meaningful demonstration of what CRISPR can accomplish

article thumbnail

Managing drug shortages: Getting medicines to patients in need

Pharmaceutical Technology

Ongoing drug shortages are not a new occurrence, but a rise in shortages following the pandemic and other global events is leaving many patients unable to access the medicines they need. Enabling Access to Medicines: What Manufacturers and Patients Need to Know. <p>Early

Medicine 191
article thumbnail

Intrinsic Medicine enters merger with Phoenix Biotech

Pharmaceutical Technology

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. The post Intrinsic Medicine enters merger with Phoenix Biotech appeared first on Pharmaceutical Technology.

Medicine 141
article thumbnail

Third Rock-backed Faze Medicines shutters two years after launch

Bio Pharma Dive

The startup, which focused on biomolecular condensates, is calling it quits after “the science did not progress sufficiently to meet our bar for further investment,” a spokesperson said

Medicine 158
article thumbnail

Is digital the future of medicine?

World of DTC Marketing

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June.

Medicine 177
article thumbnail

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

Bio Pharma Dive

Relyvrio, a drug developed by Amylyx Pharmaceuticals, is in high demand in ALS clinics across the U.S. Though some patients are already getting it, insurance coverage and out-of-pocket costs remain a source of anxiety

Doctors 216
article thumbnail

Scottish Medicines Consortium recommends Merck’s Tepmetko

Pharma Times

Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients

Medicine 117
article thumbnail

Magazine: Medicine in outer space

Pharmaceutical Technology

In this issue, we take a look at tools and guidelines being developed to not just study but also manufacture medicines away from the planet. The post Magazine: Medicine in outer space appeared first on Pharmaceutical Technology. Space agencies and private companies the world over are inching closer to their plans of taking humans to the moon and eventually to Mars.

Medicine 100
article thumbnail

Worms as a model for personalized medicine

Scienmag

Tailoring a person’s diet or medicine based on their genomes has been a goal of the medical community for decades, but the strategy has not been widely successful because people metabolize chemicals differently. Medicine & Health Medicine model personalized worms

article thumbnail

Pfizer buys into Biohaven's fast-selling migraine medicine

Bio Pharma Dive

The pharmaceutical giant will pay Biohaven $500 million for ex-U.S. rights to rimegepant — a sizable licensing deal, though not the buyout that some of the biotech's investors appeared to be hoping for

Medicine 224
article thumbnail

Pfizer pledges not-for-profit sale of medicines in low-income countries

Bio Pharma Dive

The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.

Sales 206
article thumbnail

Prime Medicine becomes the next high-profile biotech to test the IPO waters

Bio Pharma Dive

The startup, which launched last year with $315 million in funding and plans to advance a new form of gene editing, is one of the first big venture-backed biotechs in several months to seek an IPO

article thumbnail

Crossed wires? Mixed messages on medicines

Pharma Phorum

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines.

article thumbnail

Belharra and Genentech partner for small molecule medicines development

Pharmaceutical Technology

Belharra Therapeutics and Roche Group member Genentech have announced a partnership for the discovery and development of new small molecule medicines across several therapeutic areas.

Medicine 130
article thumbnail

Blueprint Medicines announces financing partnerships for $1.25bn

Pharmaceutical Technology

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. The post Blueprint Medicines announces financing partnerships for $1.25bn appeared first on Pharmaceutical Technology.

Medicine 141
article thumbnail

Microbiota medicine: towards clinical revolution

Scienmag

Biology clinical Medicine microbiota revolutionAfter the last meeting of the International Society of Microbiota (ISM), a well-documented report and statement were published.

article thumbnail

A new startup gets Takeda's backing to take complex genetic medicines 'off the shelf'

Bio Pharma Dive

Ensoma Therapeutics debuts with a lucrative alliance with the Japanese pharma and an unusual way to deliver genetic medicines into the body

Genetics 259
article thumbnail

Digital medicine company Akili gets cold market reception after blank-check merger

Bio Pharma Dive

After spiking on news of the merger’s close, shares in the ADHD treatment developer fell sharply in trading Monday and again on Tuesday

Medicine 230
article thumbnail

Lilly pays $880M for Prevail, pushing further into genetic medicine

Bio Pharma Dive

The acquisition marks a significant bet by Lilly on gene therapy's potential to address tough-to-treat neurological disorders like Parkinson's disease

Genetics 247
article thumbnail

Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service

Pharma Mirror

The post Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service appeared first on Pharma Mirror Magazine. Pharmaceutical News Medicine Delivery Service Okapi Toppan

Pharmacy 130
article thumbnail

Nanochannels light the way towards new medicine

Scienmag

Social & Behavioral Science light Medicine nanochannelsTo develop new drugs and vaccines, detailed knowledge about nature’s smallest biological building blocks – the biomolecules – is required.

DNA 71
article thumbnail

Driving clinical trial innovation forward with precision medicine

Pharma Phorum

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify.

article thumbnail

Lack of medicines in Greece and the solution of Generics

Pharma Tutor

Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens

article thumbnail

Diving arising antimalarial medicine resistance in Africa

The Pharma Data

Diving arising antimalarial medicine resistance in Africa. Although antimalarial medicine resistance is a serious cause for concern, artemisinin- grounded combination curatives( ACTs) remain the stylish available treatment for uncomplicatedP. WHO is launching moment a new strategy to respond to the critical problem of antimalarial medicine resistance in Africa. ACTs combine an artemisinin outgrowth( artesunate, artemether or dihydroartemisinin) with a mate medicine.

article thumbnail

RVAC Medicines, A*STAR partner for mRNA manufacturing expertise

Pharmaceutical Technology

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.

article thumbnail

Multi-drug precision medicine cancer trial begins

Pharma Times

Patients on the trial will have one of the particular genetic mutations among rare cancers

Genetics 107
article thumbnail

LifeArc and MRC launch toolkit to navigate medicines repurposing

Pharma Times

Medicines repurposing offers new avenues for treating a range of common and rare diseases

Medicine 111
article thumbnail

Self-reported Sexual Harassment and Subsequent Reporting Among Internal Medicine Residents in the US

JAMA Internal Medicine

This study uses survey data to describe the types of sexual harassment experienced by internal medicine residents, their knowledge of reporting mechanisms, their reporting intentions and actions, and satisfaction with reporting outcomes

article thumbnail

Call to arms as UK falls back in medicines manufacturing

Pharma Phorum

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. The post Call to arms as UK falls back in medicines manufacturing appeared first on.

article thumbnail

Gemini enters business combination deal with Disc Medicine

Pharmaceutical Technology

Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US.

Medicine 141
article thumbnail

German Merck buys manufacturer of key component in mRNA medicines

Bio Pharma Dive

Merck KGaA is buying Indianapolis-based Exelead, a specialist in the lipid nanoparticles used to ferry mRNA into the body, for $780 million in cash